Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills Candida albicans |
| |
| Authors: | Jakub Suchodolski Jakub Muraszko Przemys&#x;aw Bernat Anna Krasowska |
| |
| Affiliation: | 1.Department of Biotransformation, Faculty of Biotechnology, University of Wrocław, 50-383 Wrocław, Poland; (J.S.); (J.M.);2.Department of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of Łódź, 90-237 Łódź, Poland; |
| |
| Abstract: | Candida albicans is an opportunistic pathogen that induces vulvovaginal candidiasis (VVC), among other diseases. In the vaginal environment, the source of carbon for C. albicans can be either lactic acid or its dissociated form, lactate. It has been shown that lactate, similar to the popular antifungal drug fluconazole (FLC), reduces the expression of the ERG11 gene and hence the amount of ergosterol in the plasma membrane. The Cdr1 transporter that effluxes xenobiotics from C. albicans cells, including FLC, is delocalized from the plasma membrane to a vacuole under the influence of lactate. Despite the overexpression of the CDR1 gene and the increased activity of Cdr1p, C. albicans is fourfold more sensitive to FLC in the presence of lactate than when glucose is the source of carbon. We propose synergistic effects of lactate and FLC in that they block Cdr1 activity by delocalization due to changes in the ergosterol content of the plasma membrane. |
| |
| Keywords: | Candida albicans lactate fluconazole ergosterol Cdr1 |
|
|
